Balentine LLC Natera, Inc. Transaction History
Balentine LLC
- $3.35 Billion
- Q1 2024
A detailed history of Balentine LLC transactions in Natera, Inc. stock. As of the latest transaction made, Balentine LLC holds 3,385 shares of NTRA stock, worth $374,719. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,385
Previous 3,420
1.02%
Holding current value
$374,719
Previous $214,000
44.39%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NTRA
# of Institutions
440Shares Held
117MCall Options Held
254KPut Options Held
263K-
Vanguard Group Inc Valley Forge, PA11MShares$1.22 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$815 Million0.06% of portfolio
-
Fred Alger Management, LLC New York, NY6.55MShares$725 Million3.03% of portfolio
-
Black Rock Inc. New York, NY6.49MShares$718 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.93MShares$435 Million1.68% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $10.7B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...